A decision tool for predicting sentinel node accuracy from breast tumor size and grade

Breast Journal

Volumn 13, Issue 6, 2007, Pages 593-598

  Coombs, Nathan ^a,d   Chen, Wanqing ^b,e   Taylor, Richard ^a,b,c,f   Boyages, John ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CUMBERLAND HOSPITAL   (Australia)

^d Great Western Breast Care Centre   (United Kingdom)

^e PEKING UNION MEDICAL COLLEGE   (China)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast tumor grade; Breast tumor size; Decision tool; Predicting accuracy; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY DISSECTION; BREAST CARCINOMA; BREAST TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CLINICAL DECISION MAKING; DIAGNOSTIC IMAGING; FALSE NEGATIVE RESULT; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PREDICTIVE VALIDITY; PREOPERATIVE CARE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CHI-SQUARE DISTRIBUTION; DATA INTERPRETATION, STATISTICAL; DECISION SUPPORT TECHNIQUES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEW SOUTH WALES; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 35748962900     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00507.x     Document Type: Article

References (21)

1. Carter C, Allen C., Henderson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989 63 : 181 7.
2. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001 25 : 767 72.
3. Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary node metastases in invasive breast cancer. ANZ J. Surg. 2001 71 : 723 8.
4. Ahlgren J, Stal O, Westman G, Arnesson LG. Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group. Acta Oncol 1994 33 : 603 8.
5. Laura S, Coombs NJ, Ung O, Boyages J. Tumor size as a predictor of axillary node metastases in patients with breast cancer. ANZ J Surg 2006 76 : 1002 6.
6. Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 2003 10 : 1160 5.
7. Heusinger K, Lohberg C, Lux MP, et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res Treat 2005 94 : 17 23.
8. Bosch AM, Kessels AG, Beets GL, et al. Preoperative estimation of the pathological breast tumor size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumors. Eur J Radiol 2003 48 : 285 92.
9. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 2004 37 : 73 91.
10. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003 89 : 648 52.
11. Rietman JS, Dijkstra PU, Geertzen JH, et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004 11 : 1018 24.
12. Goyal A, Newcombe RG, Mansel RE, et al. ALMANAC Trialists Group. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 2005 41 : 238 43.
13. Barone JE, Tucker JB, Perez JM, Odom SR, Ghevariya V. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 2005 71 : 66 70.
14. Hung WK, Chan MC, Mak KL, et al. Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes. ANZ J Surg 2005 75 : 27 31.
15. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE. ALMANAC Trialists Group Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 2004 40 : 1731 7.
16. Saidi RF, Dudrick PS, Remine SG, Mittal VK. Non-sentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004 70 : 101 5.
17. American Joint Committee on Cancer, American Cancer Society, American College of Surgeons. AJCC Cancer Staging Manual, 6th edn. Philadelphia : Lippincott-Raven, 2003.
18. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 2004 139 : 648 51.
19. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 349 : 1864 7.
20. Rink T, Heuser T, Fitz H, Schroth HJ, Weller E, Zippel HH. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol. Clin Nucl Med 2001 26 : 293 8.
21. Krag D, Weaver D, Ashkaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Eng J Med 1998 339 : 941 6.